Novartis Investigative Site

Kristiansand NO-4605

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Multiple Myeloma

Studies at this site

• Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma — Completed
• Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma — Completed